BRIEF-Luxottica's Del Vecchio says listing in both Italy and France still an option - report
Jan 17 Luxottica founder Leonardo del Vecchio says in an interview with Italian daily Corriere della Sera:
Nov 21 Theravance Biopharma Inc -
* Theravance Biopharma highlights filing of U.S. new drug application for the closed triple in COPD by Glaxosmithkline and Innoviva
* GSKon track for European regulatory submission for closed triple in COPD by end of 2016
* Results of impact study are expected to be reported by GSK in 2017
* Regulatory filing in EU is planned in coming weeks,is expected to be followed by submissions in other countries beginning in 2017 Source text for Eikon: Further company coverage:
PARIS, Jan 17 French retailer Casino said on Tuesday it would deliver on its French profit forecast for 2016 after fourth-quarter sales reflected an improvement in its home market on a same-store basis, notably at the Geant hypermarkets.
TOKYO, Jan 17 Japan's Nikkei fell to its lowest level in more than a month on Tuesday as a strong yen soured sentiment, while shares of Honda tumbled after it said an air bag made by Takata Corp had ruptured in one of its cars in Japan.